期刊文献+

小牛血清去蛋白注射液与小牛血去蛋白注射液有效成分含量和生物活性的比较 被引量:25

Comparative study of active ingredient content and biological activity between deproteinized calf serum injection and deproteinized calf blood injection
原文传递
导出
摘要 目的通过不同的原料和生化提取方法,制备了小牛血清去蛋白注射液(DCSI)和小牛血去蛋白注射液(DCBI),比较两者在主要成分、多肽含量、生物活性等方面的差异。方法将DCSI及DCBI制备好后,对两者进行试验对比研究,即采用高效液相色谱法进行鉴定分析,用Lowry法测定多肽含量,用瓦氏微量呼吸检压仪测定呼吸活力并计算刺激指数,测定两者对小鼠耐缺氧试验的不同影响时间。结果DCSI与DCBI相比,前者色谱的双峰面积大于总的峰面积75%,显著区别于后者的60%,并且前者在多肽含量,呼吸活性及小鼠耐缺氧时间的指标上都明显高于后者(P<0.05)。结论DCSI与DCBI之间的主要成分、主要成分的含量和生物活性有显著的差别,并且前者优于后者,从药物分析角度说明两者不是同一种产品。 Objective To observe the differences in the polypeptide and active ingredient contents and biological activity between deproteinized calf serum injection (DCSI) and deproteinized calf blood injection (DCBI). Methods DCSI and DCBI, prepared with different materials and biochemical extraction methods, were identified with high performance liquid chromatography (HPLC) and compared in the content of active ingredient with the Lowry' s way, and in the cellular respiration and stimulation index with the method ofmicrorespiromete ation decreasing. In addition, the effect of the 2 injections on the rat tolerance to anoxia was observed. Results Double-peak area accounted for more than 75% of total peak area in HPLC of DCSI, which was significantly higher than that (about 60%) in HPLC of DCBI; DCSI not only prolonged the duration of tolerance to anoxia as compared with DCBI, but also had higher biological activity and polypeptide content (P〈0.05). Conclusion There are obvious differences in the contents of active components and biological activity between DCSI and DCBI, and DCSI is better than DCBI.
作者 任淑萍
出处 《中华神经医学杂志》 CAS CSCD 2006年第8期767-769,共3页 Chinese Journal of Neuromedicine
关键词 小牛血清去蛋白注射液 小牛血去蛋白注射液 Deproteinized calf serum injection Deproteinized calf blood injection
  • 相关文献

参考文献7

  • 1Mychka VB,Chazova IE,Gomostaev VV,et al.Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome[J].Ter Arkh,2005,77(10):20-24.
  • 2Macheret IeL,Khanenko NV.Drug therapy of patients with dyscirculatory encephalopathy[J].Lik Sprava,2002,Apr-Jun,(3-4):84-87.
  • 3于鸿儒,肖建英,刘用璋,张敬国,张尤新,王铁.小牛血去蛋白提取物的生化性质及药效学的实验研究[J].药物生物技术,1998,5(1):34-37. 被引量:20
  • 4李义奎.中药药理实验方法学[M].上海:上海科学技术出版社,1991.6.
  • 5Obermaier-Kusser B,MUhlbacher C,Mushack J,et al.Further evidence for a two-step model of glucose-transport regulation[J].Biochem J,1989,261(3):699-705.
  • 6Smolianinov AB.Actovegin treatment of duodenal ulcer associated with ischemic heart disease and diabetes mellitus[J].Klin Med(Mosk),2000,78(6):24-28.
  • 7吕媛,权菊香.小牛血清去蛋白注射液对脑细胞缺血缺氧的保护作用及临床应用[J].中国临床药理学杂志,2006,22(2):141-144. 被引量:83

二级参考文献13

  • 1Levi MR.The nerve growth factor 35 years later[J].Science,1987;237:1154-1161.
  • 2Lichtman JW.Trophic factor theory matures[J].Nature,1987; 326:336.
  • 3Leibrock J.Molecular cloning and expression of brain-derived neurotrophic factor[J].Nature,1989 ;341:149-152.
  • 4Ernfors P.Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor:developmental and topographical expression in the brain[J].Proe Natl AcaD Sci USA,1990; 87:5454-5458.
  • 5Kohler N,Lipton A.Platelets as a source of fibroblast growth-promoting activity[J].Exp Cell Res,1974 ;87:297-301.
  • 6Pierson RW.The partial purification from calf serum of a fraction with multiplication-stimulating activity for chicken fibroblasts in cell culture and with non-suppressible insulin-like activity[J].J Cell Physiol,1972 ;79:319-329.
  • 7Grspodarowicz D.Purification of fibroblast growth factor from bovine pituitary[J].J Biol Chem,1974 ;250:2515-2520.
  • 8赵性泉.小牛血清去蛋白注射治疗急性脑缺血性脑损害临床试验的研究[J].中国临床药理学杂志,2006,22.
  • 9陈宝生,赵颖,方宏钧.爱维治与传统方法治疗急性脑梗塞的临床对照[J].上海医药,1997(6):12-13. 被引量:1
  • 10刘泰.爱维治~治疗老年急性脑梗塞疗效研究[J].国外医药(合成药.生化药.制剂分册),2000,21(1):19-20. 被引量:2

共引文献117

同被引文献162

引证文献25

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部